| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Departments of Dermatology,*
Internal Medicine
(Division of Oncology),
Pathology,
and
Surgery,
University Hospital Zurich,
Zurich, Switzerland
Immune evasion in lung cancer results from both structural and functional alterations of human leukocyte antigen (HLA) class I molecules and the local release of immunosuppressive cytokines. Recent data suggest that HLA-G, a nonclassical class Ib molecule, is involved in immune evasion by tumor cells. We sought to determine whether HLA-G could contribute to immunescape in lung cancer. All of 19 tumor specimens examined demonstrated detectable membrane-bound (HLA-G1), as well as soluble (HLA-G5) isoform transcription. Nine of 34 (26%) tumors were positive by immunohistochemistry using monoclonal antibody (mAb) 4H84, recognizing all denatured HLA-G isoforms, of which six were positive using mAb 16G1, recognizing soluble HLA-G. HLA-G immunoreactivity correlated with high-grade histology, with HLA-G being preferentially expressed on large-cell carcinomas. In these patients, loss of classical HLA class I molecules was observed to associate with HLA-G protein up-regulation. Moreover, we found interleukin-10 expressed in 15 of 34 (44%) tumors, and in most of the HLA-G-positive cases (7 of 9), suggesting up-modulation of HLA-G by interleukin-10. It is conceivable that HLA-G expression in lung cancer might be one of the ways how the tumor down-regulates host immune response, in addition to interleukin-10 production and HLA class I loss.
This article has been cited by other articles:
 |
|
 |
|
  S.-m. Yie, H. Yang, S.-r. Ye, K. Li, D.-d. Dong, and X.-m. Lin Expression of Human Leukocyte Antigen G (HLA-G) Correlates with Poor Prognosis in Gastric Carcinoma Ann. Surg. Oncol., October 1, 2007; 14(10): 2721 - 2729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Feger, E. Tolosa, Y.-H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation Blood, July 15, 2007; 110(2): 568 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Morandi, I. Levreri, P. Bocca, B. Galleni, L. Raffaghello, S. Ferrone, I. Prigione, and V. Pistoia Human Neuroblastoma Cells Trigger an Immunosuppressive Program in Monocytes by Stimulating Soluble HLA-G Release Cancer Res., July 1, 2007; 67(13): 6433 - 6441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rouas-Freiss, P. Moreau, S. Ferrone, and E. D. Carosella HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism? Cancer Res., November 15, 2005; 65(22): 10139 - 10144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nuckel, V. Rebmann, J. Durig, U. Duhrsen, and H. Grosse-Wilde HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia Blood, February 15, 2005; 105(4): 1694 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Le Friec, F. Gros, Y. Sebti, V. Guilloux, C. Pangault, R. Fauchet, and L. Amiot Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules J. Leukoc. Biol., December 1, 2004; 76(6): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. LeMaoult, I. Krawice-Radanne, J. Dausset, and E. D. Carosella HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells PNAS, May 4, 2004; 101(18): 7064 - 7069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-M. Shih and R. J. Kurman Ovarian Tumorigenesis: A Proposed Model Based on Morphological and Molecular Genetic Analysis Am. J. Pathol., May 1, 2004; 164(5): 1511 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Urosevic, T. Maier, B. Benninghoff, H. Slade, G. Burg, and R. Dummer Mechanisms Underlying Imiquimod-Induced Regression of Basal Cell Carcinoma In Vivo Arch Dermatol, October 1, 2003; 139(10): 1325 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Singer, V. Rebmann, Y.-C. Chen, H.-T. Liu, S. Z. Ali, J. Reinsberg, M. T. McMaster, K. Pfeiffer, D. W. Chan, E. Wardelmann, et al. HLA-G Is a Potential Tumor Marker in Malignant Ascites Clin. Cancer Res., October 1, 2003; 9(12): 4460 - 4464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bukur, V. Rebmann, H. Grosse-Wilde, H. Luboldt, H. Ruebben, I. Drexler, G. Sutter, C. Huber, and B. Seliger Functional Role of Human Leukocyte Antigen-G Up-Regulation in Renal Cell Carcinoma Cancer Res., July 15, 2003; 63(14): 4107 - 4111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Moreau, G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella HLA-G gene repression is reversed by demethylation PNAS, February 4, 2003; 100(3): 1191 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Ibrahim, Y. Allory, F. Commo, B. Gattegno, P. Callard, and P. Paul Altered Pattern of Major Histocompatibility Complex Expression in Renal Carcinoma: Tumor-Specific Expression of the Nonclassical Human Leukocyte Antigen-G Molecule Is Restricted to Clear Cell Carcinoma While Up-Regulation of Other Major Histocompatibility Complex Antigens Is Primarily Distributed in All Subtypes of Renal Carcinoma Am. J. Pathol., February 1, 2003; 162(2): 501 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Ryan, R. L. Grendell, D. E. Geraghty, and T. G. Golos A Soluble Isoform of the Rhesus Monkey Nonclassical MHC Class I Molecule Mamu-AG Is Expressed in the Placenta and the Testis J. Immunol., July 15, 2002; 169(2): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
